Market closedNon-fractional
Repro Med Systems/KRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Repro Med Systems
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Ticker
KRMD
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Mahwah, United States
Employees
-
Website
www.korumedical.com
KRMD Metrics
BasicAdvanced
$115M
Market cap
-
P/E ratio
-$0.29
EPS
0.53
Beta
-
Dividend rate
Price and volume
Market cap
$115M
Beta
0.53
Financial strength
Current ratio
4.014
Quick ratio
3.194
Long term debt to equity
18.465
Total debt to equity
21.825
Management effectiveness
Return on assets (TTM)
-17.44%
Return on equity (TTM)
-54.24%
Valuation
Price to revenue (TTM)
3.924
Price to book
6
Price to tangible book (TTM)
6.24
Price to free cash flow (TTM)
-92.599
Growth
Revenue change (TTM)
0.96%
Earnings per share change (TTM)
53.91%
3-year revenue growth
8.00%
3-year earnings per share growth
61.33%
What the Analysts think about KRMD
Analyst Ratings
Majority rating from 5 analysts.
KRMD Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.1M
14.08%
Net income
-$1.9M
-74.32%
Profit margin
-23.45%
-77.50%
KRMD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.05
-$0.03
-$0.16
-$0.04
-
Expected
-$0.06
-$0.05
-$0.04
-$0.04
-$0.04
Surprise
-11.77%
-40.00%
300.00%
5.26%
-
KRMD News
AllArticlesVideos
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
Business Wire·2 months ago
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Repro Med Systems stock?
Repro Med Systems (KRMD) has a market cap of $115M as of July 06, 2024.
What is the P/E ratio for Repro Med Systems stock?
The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of July 06, 2024.
Does Repro Med Systems stock pay dividends?
No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Repro Med Systems dividend payment date?
Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Repro Med Systems?
Repro Med Systems (KRMD) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Repro Med Systems stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.